Distribution of nerve growth factor in cat brains following topical application of solution or Minipellet

Neurological Research

Volumn 20, Issue 2, 1998, Pages 116-120

  Takemoto, Osamu ^a   Yoshimine, Toshiki ^a   Muhammad, A K M Ghulam ^a   Maruno, Motohiko ^a   Yamamoto, Satoshi ^a   Fujioka, Keiji ^b   Koseki, Norimasa ^b   Takada, Yoshihiro ^b   Sano, Akihiko ^b   Maeda, Hiroo ^b   Hayakawa, Toru ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b DAINIPPON SUMITOMO PHARMA CO LTD   (Japan)

Author keywords

Cat brain; Delivery; Distribution; Nerve growth factor (NGF); Pellet

Indexed keywords

NERVE GROWTH FACTOR; PLACEBO; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CAT; CAUDATE NUCLEUS; CEREBELLUM; CEREBROSPINAL FLUID LEVEL; CONTROLLED STUDY; DRUG DISTRIBUTION; DRUG IMPLANT; DRUG PELLET; DRUG SOLUTION; DRUG TISSUE LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; NONHUMAN; TOPICAL DRUG ADMINISTRATION;

EID: 0031952204     PISSN: 01616412     EISSN: None     Source Type: Journal    
DOI: 10.1080/01616412.1998.11740492     Document Type: Article

References (26)

1. Kromer LF. Nerve growth factor treatment after brain injury prevents neuronal death. Science 1987; 235: 214-216
2. Jelsma TN, Aguayo AJ. Trophic factors. Curr Opin Neurobiol 1994; 4: 717-725
3. Cuevas-Sanchez P. How neurotrophic factors protect brain against excitotoxicity. Surg Neurol 1996; 46: 152-153
4. Olson L, Backlund EO, Ebendal T, Freedman R, Hamberger B, Hansson P, Hoffer B, Lindblom U, Meyerson B, Stromberg I, Sydow O, Seiger A. Intraputaminal infusion of nerve growth factor to support adrenal medullary autografts in Parkinson's disease. Arch Neural 1991; 48: 373-381
5. Olson L. NGF and the treatment of Alzheimer's disease. Exp Neurol 1993; 124: 5-15
6. Barinaga M. Neurotrophic factors enter the clinic [news]. Science 1994; 264: 772-774
7. Mattson MP, Scheff SW. Endogenous neuroprotection factors and traumatic brain injury: Mechanisms of action and implications for therapy. J Neurotrauma 1994; 11: 3-33
8. Friden PM, Walus LR, Watson P, Doctrow SR, Kozarich JW, Bäckman C, Bergman H, Hoffer B, Bloom F, Granholm A-C. Blood-brain barrier penetration and in vivo activity of an NGF conjugate. Science 1993; 259: 373-377
9. Poduslo JF, Curran GL, Berg CT. Macromolecular permeability across the blood-nerve and blood-brain barriers. Proc Natl Acad Sci USA 1994; 91: 5705-5709
10. Yamamoto S, Yoshimine T, Fujita T, Kuroda R, Irie T, Fujioka K, Hayakawa T. Protective effect of NGF atelocollagen Minipellet on the hippocampal delayed neuronal death in gerbils. Neurosci Lett 1992; 141: 161-165
11. Ferguson IA, Schweitzer JB, Bartlett PF, Johnson EM. Receptor-mediated retrograde transport in CNS neurons after intraventricular administration of NGF and growth factors. J Comp Neurol 1991; 313: 680-692
12. Lapchak PA, Araudo DM, Carswell S, Hefti F. Distribution of [125I]nerve growth factor in the rat brain following a single intraventricular injection: Correlation with the topographic distribution of trkA messenger RNA-expressing cells. Neurosci 1993; 54: 445-460
13. Krewson CE, Klarman ML, Saltzman WM. Distribution of nerve growth factor following direct delivery to brain interstitium. Brain Res 1995; 680: 196-206
14. Emmett CJ, Stewart GR, Johnson RM, Aswani SP, Chan RL, Jakeman LB. Distribution of radioiodinated recombinant human nerve growth factor in primate brain following intracerebrovascular infusion. Exp Neurol 1996; 140: 151-160
15. Fujiwara T, Sakagami K, Matsuoka J, Shiozaki S, Uchida S, Fujioka K, Takada H, Onoda T, Orita K. Application of an interleukin 2 slow delivery system to the immunotherapy of established murine colon 26 adenocarcinoma liver metastasis. Cancer Res 1990; 50: 7003-7007
16. Snider RS, Neimer WT. A Stereotaxic Atlas of the Cat Brain, Chicago: The University of Chicago Press, 1961
17. Hammerschlag R, Brady ST. Axonal transport and the neuronal cytoskeleton. In: Siegel GJ, Agranoff BW, Albers RW, Molinoff PB, eds. Basic Neurochemistry. Molecular, Cellular, and Medical Aspects, 4th edn. New York: Raven Press, 1989: pp. 457-477
18. Richardson PM, Verge Issa VKM, Riopelle RJ. Distribution of neuronal receptors for nerve growth factor in rat. J Neurosci 1986; 6: 2312-2321
19. Middleton FA, Strick PL. The temporal lobe is a target of output from the basal ganglia. Proc Natl Acad Sci USA 1996; 93: 8683-8687
20. Fenstermacher JD, Kaye T. Drug diffusion within the brain. Ann NY Acad Sci 1988; 531: 29-39
21. Saltzman WM, Radmsky ML. Drugs released from polymers: Diffusion and elimination in brain tissue. Chem Eng Sci 1991; 46: 2429-2444
22. Becker NH, Hirano A, Zimmerman HM. Observations of the distribution of exogenous peroxidase in the rat cerebrum. J Neuropath Exp Neurol 1968; 27: 439-452
23. Rosenberg GA, Kyner WT, Estrada E. Bulk flow of brain interstitial fluid under normal and hyperosmolar conditions. Am J Physiol 1980; 238: F42-F49
24. Reulen HJ, Graham R, Spatz M, Klatzo I. Role of pressure gradients and bulk flow in dynamics of vasogenic brain edema. J Neurosurg 1977; 46: 24-35
25. Williams LR, Varon S, Peterson GM, Wictorin K, Fischer W, Bjorklund A, Gage FH. Continuous infusion of nerve growth factor prevents basal forebrain neuronal death after fimbria fornix transection. Proc Natl Acad Sci USA 1986; 83: 9231-9235
26. Matsuda S, Saito H, Nishiyama N. Basic fibroblast growth factor suppressed the enhancement of choline acetyltransferase activity induced by nerve growth factor. Neurosci Lett 1990; 114: 69-74